HARVARD BIOSCIENCE INC's ticker is HBIO and the CUSIP is 416906105. A total of 62 filers reported holding HARVARD BIOSCIENCE INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $9,000 | -89.8% | 3,506 | -89.6% | 0.01% | -89.0% |
Q1 2017 | $88,000 | -56.2% | 33,826 | -48.8% | 0.07% | -12.0% |
Q4 2016 | $201,000 | +474.3% | 66,022 | +419.7% | 0.08% | +260.9% |
Q3 2016 | $35,000 | +105.9% | 12,703 | +108.8% | 0.02% | +76.9% |
Q2 2016 | $17,000 | +70.0% | 6,083 | +79.8% | 0.01% | +85.7% |
Q1 2016 | $10,000 | – | 3,383 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Harvey Partners, LLC | 790,000 | $2,378,000 | 3.09% |
Alambic Investment Management, L.P. | 25,398 | $76,000 | 0.83% |
Adirondack Research & Management Inc. | 190,494 | $573,000 | 0.80% |
Archon Capital Management LLC | 881,794 | $2,654,000 | 0.53% |
BARD ASSOCIATES INC | 1,483,610 | $4,465,000 | 0.47% |
DALTON GREINER HARTMAN MAHER & CO | 909,977 | $2,739,000 | 0.45% |
PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | 1,537,800 | $4,629,000 | 0.40% |
Portolan Capital Management | 979,067 | $2,947,000 | 0.33% |
HEARTLAND ADVISORS INC | 961,400 | $2,894,000 | 0.25% |
Granahan Investment Management | 1,757,176 | $5,289,000 | 0.18% |